A detailed history of Perceptive Advisors LLC transactions in Absci Corp stock. As of the latest transaction made, Perceptive Advisors LLC holds 700,000 shares of ABSI stock, worth $1.79 Million. This represents 0.07% of its overall portfolio holdings.

Number of Shares
700,000
Previous 700,000 -0.0%
Holding current value
$1.79 Million
Previous $2.16 Million 24.03%
% of portfolio
0.07%
Previous 0.06%

Shares

5 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q1 2024

May 15, 2024

BUY
$3.41 - $5.74 $2.39 Million - $4.02 Million
700,000 New
700,000 $3.98 Million
Q2 2022

Aug 15, 2022

SELL
$3.13 - $8.83 $928,376 - $2.62 Million
-296,606 Reduced 24.9%
894,346 $2.97 Million
Q1 2022

May 16, 2022

SELL
$5.87 - $9.46 $1.3 Million - $2.09 Million
-220,824 Reduced 15.64%
1,190,952 $10 Million
Q4 2021

Feb 14, 2022

SELL
$7.88 - $18.03 $512,200 - $1.17 Million
-65,000 Reduced 4.4%
1,411,776 $11.6 Million
Q3 2021

Nov 15, 2021

BUY
$10.37 - $30.29 $15.3 Million - $44.7 Million
1,476,776 New
1,476,776 $17.2 Million

Others Institutions Holding ABSI

About Absci Corp


  • Ticker ABSI
  • Exchange NASDAQ
  • Sector Healthcare
  • Industry Biotechnology
  • Shares Outstandng 92,843,504
  • Market Cap $238M
  • Description
  • Absci Corporation, a drug and target discovery company, provides biologic drug candidates and production cell lines using integrated drug creation platform for partners in the United States. Its integrated drug creation platform enables the creation of biologics by unifying the drug discovery and cell line development processes into one process....
More about ABSI
Track This Portfolio

Track Perceptive Advisors LLC Portfolio

Follow Perceptive Advisors LLC and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Perceptive Advisors LLC, based on Form 13F filings with the SEC.

News

Stay updated on Perceptive Advisors LLC with notifications on news.